{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:24:11Z","timestamp":1785284651558,"version":"3.55.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Department of Biotechnology, Government of India","award":["RLS\/BT\/Re-entry\/05\/2012"],"award-info":[{"award-number":["RLS\/BT\/Re-entry\/05\/2012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pancreatic Ductal Adenocarcinoma (PDAC) is a cancer of the exocrine pancreas and 5-year survival rates remain constant at 7%. Along with PDAC, Periampullary Adenocarcinoma (PAC) accounts for 0.5\u20132% of all gastrointestinal malignancies. Genomic observations were well concluded for PDAC and PACs in western countries but no reports are available from India till now.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Targeted Next Generation Sequencing were performed in 8 (5 PDAC and 3 PAC) tumour normal pairs, using a panel of 412 cancer related genes. Primary findings were replicated in 85 tumour samples (31 PDAC and 54 PAC) using the Sanger sequencing. Mutations were also validated by ASPCR, RFLP, and Ion Torrent sequencing. IHC along with molecular dynamics and docking studies were performed for the <jats:italic>p.A138V<\/jats:italic> mutant of <jats:italic>TP53<\/jats:italic>. Key polymorphisms at <jats:italic>TP53<\/jats:italic> and its associated genes were genotyped by PCR-RFLP method and association with somatic mutations were evaluated. All survival analysis was done using the Kaplan-Meier survival method which\u00a0revealed that the survival rates varied significantly depending on the somatic mutations the patients harboured.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among the total 114 detected somatic mutations, <jats:italic>TP53<\/jats:italic> was the most frequently mutated (41%) gene, followed by <jats:italic>KRAS<\/jats:italic>, <jats:italic>SMAD4<\/jats:italic>, <jats:italic>CTNNB1<\/jats:italic>, and <jats:italic>ERBB3.<\/jats:italic> We identified a novel hotspot <jats:italic>TP53<\/jats:italic> mutation (<jats:italic>p.A138V<\/jats:italic>, in 17% of all patients). Low frequency of <jats:italic>KRAS<\/jats:italic> mutation (33%) was detected in these samples compared to patients from Western counties. Molecular Dynamics (MD) simulation and DNA-protein docking analysis predicted <jats:italic>p.A138V<\/jats:italic> to have oncogenic characteristics. Patients with <jats:italic>p.A138V<\/jats:italic> mutation showed poorer overall survival (<jats:italic>p\u2009=\u20090.01<\/jats:italic>). So, our finding highlights elevated prevalence of the p53<jats:italic>p.A138V<\/jats:italic> somatic mutation in PDAC and pancreatobiliary PAC patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Detection of <jats:italic>p.A138V<\/jats:italic> somatic variant in <jats:italic>TP53<\/jats:italic> might serve as a prognostic\u00a0marker to classify patients. It might also have a role in determining treatment regimes. In addition, low frequency of <jats:italic>KRAS<\/jats:italic> hotspot mutation mostly in Indian PDAC patient cohort indicates presence of other early drivers in malignant transformation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10020-020-00183-1","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T13:03:53Z","timestamp":1592399033000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["A novel hotspot and rare somatic mutation p.A138V, at TP53 is associated with poor survival of pancreatic ductal and periampullary adenocarcinoma patients"],"prefix":"10.1186","volume":"26","author":[{"given":"Gourab","family":"Saha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argha","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subrata","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esita","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasun","family":"Panja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paromita","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navonil","family":"DeSarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supriyo","family":"Ghatak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibajyoti","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeep","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bidyut","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipankar","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhan K.","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4465-472X","authenticated-orcid":false,"given":"Nilabja","family":"Sikdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,17]]},"reference":[{"issue":"1","key":"183_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/mc.20779","volume":"51","author":"G Andreotti","year":"2012","unstructured":"Andreotti G, Silverman DT. Occupational risk factors and pancreatic cancer: a review of recent findings. Mol Carcinog. 2012;51(1):98\u2013108.","journal-title":"Mol Carcinog"},{"issue":"14","key":"183_CR2","doi-asserted-by":"publisher","first-page":"12796","DOI":"10.18632\/oncotarget.3473","volume":"6","author":"E Assenat","year":"2015","unstructured":"Assenat E, Azria D, Mollevi C, Guimbaud R, Tubiana-Mathieu N, Smith D, et al. Dual targeting of HER1\/EGFR and HER2 with cetuximab and trastuzumab in patients with metastatic pancreatic cancer after gemcitabine failure: results of the \"THERAPY\"phase 1-2 trial. Oncotarget. 2015;6(14):12796\u2013808.","journal-title":"Oncotarget"},{"issue":"2","key":"183_CR3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.cell.2018.02.060","volume":"173","author":"MH Bailey","year":"2018","unstructured":"Bailey MH, Tokheim C, Porta-Pardo E, Sengupta S, Bertrand D, Weerasinghe A, et al. Comprehensive characterization of Cancer driver genes and mutations. Cell. 2018;173(2):371\u201385 e18.","journal-title":"Cell"},{"issue":"7592","key":"183_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey P, Chang DK, Nones K, Johns AL, Patch AM, Gingras MC, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016;531(7592):47\u201352.","journal-title":"Nature"},{"issue":"16","key":"183_CR5","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1002\/jcc.20292","volume":"26","author":"JL Banks","year":"2005","unstructured":"Banks JL, Beard HS, Cao Y, Cho AE, Damm W, Farid R, et al. Integrated modeling program, applied chemical theory (IMPACT). J Comput Chem. 2005;26(16):1752\u201380.","journal-title":"J Comput Chem"},{"issue":"7424","key":"183_CR6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nature11547","volume":"491","author":"AV Biankin","year":"2012","unstructured":"Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, Johns AL, et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature. 2012;491(7424):399\u2013405.","journal-title":"Nature"},{"issue":"1","key":"183_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13046-018-0705-7","volume":"37","author":"G Blandino","year":"2018","unstructured":"Blandino G, Di Agostino S. New therapeutic strategies to treat human cancers expressing mutant p53 proteins. J Exp Clin Cancer Res. 2018;37(1):30.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"183_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tibs.2013.12.004","volume":"39","author":"KL Bryant","year":"2014","unstructured":"Bryant KL, Mancias JD, Kimmelman AC, Der CJ. KRAS: feeding pancreatic cancer proliferation. Trends Biochem Sci. 2014;39(2):91\u2013100.","journal-title":"Trends Biochem Sci"},{"key":"183_CR9","unstructured":"Cancer Genome Atlas Research Network. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell. 2017;32(2):185\u2013203 e13."},{"issue":"1","key":"183_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1097\/MPA.0000000000000385","volume":"45","author":"MD Chandrasegaram","year":"2016","unstructured":"Chandrasegaram MD, Chen JW, Price TJ, Zalcberg J, Sjoquist K, Merrett ND. Advances in molecular pathology and treatment of Periampullary cancers. Pancreas. 2016;45(1):32\u20139.","journal-title":"Pancreas"},{"issue":"16","key":"183_CR11","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1093\/bioinformatics\/btv195","volume":"31","author":"Y Choi","year":"2015","unstructured":"Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 2015;31(16):2745\u20137.","journal-title":"Bioinformatics"},{"issue":"11","key":"183_CR12","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1038\/bjc.2014.401","volume":"111","author":"A Choughule","year":"2014","unstructured":"Choughule A, Sharma R, Trivedi V, Thavamani A, Noronha V, Joshi A, et al. Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer. Br J Cancer. 2014;111(11):2203\u20134.","journal-title":"Br J Cancer"},{"issue":"11","key":"183_CR13","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1038\/labinvest.2012.126","volume":"92","author":"M Christgen","year":"2012","unstructured":"Christgen M, Noskowicz M, Heil C, Schipper E, Christgen H, Geffers R, et al. IPH-926 lobular breast cancer cells harbor a p53 mutant with temperature-sensitive functional activity and allow for profiling of p53-responsive genes. Lab Investig. 2012;92(11):1635\u201347.","journal-title":"Lab Investig"},{"issue":"3","key":"183_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013;31(3):213\u20139.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"183_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/PPO.0000000000000011","volume":"20","author":"RW Cowan","year":"2014","unstructured":"Cowan RW, Maitra A. Genetic progression of pancreatic cancer. Cancer J. 2014;20(1):80\u20134.","journal-title":"Cancer J"},{"issue":"10","key":"183_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002238","volume":"7","author":"O Demir","year":"2011","unstructured":"Demir O, Baronio R, Salehi F, Wassman CD, Hall L, Hatfield GW, et al. Ensemble-based computational approach discriminates functional activity of p53 cancer and rescue mutants. PLoS Comput Biol. 2011;7(10):e1002238.","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"183_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/mc.20786","volume":"51","author":"EJ Duell","year":"2012","unstructured":"Duell EJ. Epidemiology and potential mechanisms of tobacco smoking and heavy alcohol consumption in pancreatic cancer. Mol Carcinog. 2012;51(1):40\u201352.","journal-title":"Mol Carcinog"},{"issue":"5","key":"183_CR18","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/bjc.2014.215","volume":"111","author":"S Eser","year":"2014","unstructured":"Eser S, Schnieke A, Schneider G, Saur D. Oncogenic KRAS signalling in pancreatic cancer. Br J Cancer. 2014;111(5):817\u201322.","journal-title":"Br J Cancer"},{"issue":"6","key":"183_CR19","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.cmet.2013.05.002","volume":"17","author":"S Ezzat","year":"2013","unstructured":"Ezzat S, Zheng L, Florez JC, Stefan N, Mayr T, Hliang MM, et al. The cancer-associated FGFR4-G388R polymorphism enhances pancreatic insulin secretion and modifies the risk of diabetes. Cell Metab. 2013;17(6):929\u201340.","journal-title":"Cell Metab"},{"issue":"D1","key":"183_CR20","doi-asserted-by":"publisher","first-page":"D777","DOI":"10.1093\/nar\/gkw1121","volume":"45","author":"SA Forbes","year":"2017","unstructured":"Forbes SA, Beare D, Boutselakis H, Bamford S, Bindal N, Tate J, et al. COSMIC: somatic cancer genetics at high-resolution. Nucleic Acids Res. 2017;45(D1):D777\u2013D83.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"183_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ajpath.2018.03.020","volume":"189","author":"TMH Gall","year":"2019","unstructured":"Gall TMH, Belete S, Khanderia E, Frampton AE, Jiao LR. Circulating tumor cells and cell-free DNA in pancreatic ductal adenocarcinoma. Am J Pathol. 2019;189(1):71\u201381.","journal-title":"Am J Pathol"},{"issue":"1","key":"183_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13073-016-0393-x","volume":"9","author":"J Gao","year":"2017","unstructured":"Gao J, Chang MT, Johnsen HC, Gao SP, Sylvester BE, Sumer SO, et al. 3D clusters of somatic mutations in cancer reveal numerous rare mutations as functional targets. Genome Med. 2017;9(1):4.","journal-title":"Genome Med"},{"issue":"4","key":"183_CR23","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.celrep.2015.12.005","volume":"14","author":"M-C Gingras","year":"2016","unstructured":"Gingras M-C, Covington Kyle R, Chang David K, Donehower Lawrence A, Gill Anthony J, Ittmann Michael M, et al. Ampullary Cancers Harbor ELF3 tumor suppressor gene mutations and exhibit frequent WNT Dysregulation. Cell Rep. 2016;14(4):907\u201319.","journal-title":"Cell Rep"},{"issue":"9","key":"183_CR24","doi-asserted-by":"publisher","first-page":"r106","DOI":"10.1186\/gb-2013-14-9-r106","volume":"14","author":"A Gonzalez-Perez","year":"2013","unstructured":"Gonzalez-Perez A, Jene-Sanz A, Lopez-Bigas N. The mutational landscape of chromatin regulatory factors across 4,623 tumor samples. Genome Biol. 2013;14(9):r106.","journal-title":"Genome Biol"},{"issue":"18","key":"183_CR25","first-page":"4855","volume":"54","author":"MS Greenblatt","year":"1994","unstructured":"Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994;54(18):4855\u201378.","journal-title":"Cancer Res"},{"issue":"5","key":"183_CR26","doi-asserted-by":"publisher","first-page":"a001032","DOI":"10.1101\/cshperspect.a001032","volume":"2","author":"LF Grochola","year":"2010","unstructured":"Grochola LF, Zeron-Medina J, Meriaux S, Bond GL. Single-nucleotide polymorphisms in the p53 signaling pathway. Cold Spring Harb Perspect Biol. 2010;2(5):a001032.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"16","key":"183_CR27","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1158\/1078-0432.CCR-17-0257","volume":"23","author":"LB Guedes","year":"2017","unstructured":"Guedes LB, Almutairi F, Haffner MC, Rajoria G, Liu Z, Klimek S, et al. Analytic, Preanalytic, and clinical validation of p53 IHC for detection of TP53 missense mutation in prostate Cancer. Clin Cancer Res. 2017;23(16):4693\u2013703.","journal-title":"Clin Cancer Res"},{"key":"183_CR28","doi-asserted-by":"crossref","unstructured":"Hainaut P, Pfeifer GP. Somatic TP53 mutations in the era of genome sequencing. Cold Spring Harb Perspect Med. 2016;6(11).","DOI":"10.1101\/cshperspect.a026179"},{"issue":"8","key":"183_CR29","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/modpathol.2015.57","volume":"28","author":"JF Hechtman","year":"2015","unstructured":"Hechtman JF, Liu W, Sadowska J, Zhen L, Borsu L, Arcila ME, et al. Sequencing of 279 cancer genes in ampullary carcinoma reveals trends relating to histologic subtypes and frequent amplification and overexpression of ERBB2 (HER2). Mod Pathol. 2015;28(8):1123\u20139.","journal-title":"Mod Pathol"},{"issue":"10","key":"183_CR30","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1101\/gad.1415606","volume":"20","author":"AF Hezel","year":"2006","unstructured":"Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 2006;20(10):1218\u201349.","journal-title":"Genes Dev"},{"issue":"2","key":"183_CR31","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0027-5107(98)00131-6","volume":"405","author":"M Hollstein","year":"1998","unstructured":"Hollstein M, Moeckel G, Hergenhahn M, Spiegelhalder B, Keil M, Werle-Schneider G, et al. On the origins of tumor mutations in cancer genes: insights from the p53 gene. Mutat Res. 1998;405(2):145\u201354.","journal-title":"Mutat Res"},{"issue":"8","key":"183_CR32","first-page":"2969","volume":"6","author":"RH Hruban","year":"2000","unstructured":"Hruban RH, Goggins M, Parsons J, Kern SE. Progression model for pancreatic cancer. Clin Cancer Res. 2000;6(8):2969\u201372.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"183_CR33","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1373\/clinchem.2015.238543","volume":"61","author":"J Huang","year":"2015","unstructured":"Huang J, Lohr JM, Nilsson M, Segersvard R, Matsson H, Verbeke C, et al. Variant profiling of candidate genes in pancreatic ductal adenocarcinoma. Clin Chem. 2015;61(11):1408\u201316.","journal-title":"Clin Chem"},{"key":"183_CR34","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1038\/ncomms3873","volume":"4","author":"India Project Team of the International Cancer Genome Consortium","year":"2013","unstructured":"India Project Team of the International Cancer Genome Consortium. Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups. Nat Commun. 2013;4:2873.","journal-title":"Nat Commun"},{"issue":"5897","key":"183_CR35","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1126\/science.1164368","volume":"321","author":"S Jones","year":"2008","unstructured":"Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 2008;321(5897):1801\u20136.","journal-title":"Science"},{"issue":"8","key":"183_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134638","volume":"10","author":"B Kamaraj","year":"2015","unstructured":"Kamaraj B, Bogaerts A. Structure and function of p53-DNA complexes with inactivation and rescue mutations: a molecular dynamics simulation study. PLoS One. 2015;10(8):e0134638.","journal-title":"PLoS One"},{"issue":"4","key":"183_CR37","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/cjp2.53","volume":"2","author":"M Kobel","year":"2016","unstructured":"Kobel M, Piskorz AM, Lee S, Lui S, LePage C, Marass F, et al. Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma. J Pathol Clin Res. 2016;2(4):247\u201358.","journal-title":"J Pathol Clin Res"},{"issue":"3","key":"183_CR38","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 2012;22(3):568\u201376.","journal-title":"Genome Res"},{"issue":"12","key":"183_CR39","doi-asserted-by":"publisher","first-page":"9576","DOI":"10.3390\/ijms12129576","volume":"12","author":"P Koedrith","year":"2011","unstructured":"Koedrith P, Seo YR. Advances in carcinogenic metal toxicity and potential molecular markers. Int J Mol Sci. 2011;12(12):9576\u201395.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"183_CR40","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.molcel.2018.08.013","volume":"71","author":"E Kotler","year":"2018","unstructured":"Kotler E, Shani O, Goldfeld G, Lotan-Pompan M, Tarcic O, Gershoni A, et al. A systematic p53 mutation library links differential functional impact to Cancer mutation pattern and evolutionary conservation. Mol Cell. 2018;71(5):873.","journal-title":"Mol Cell"},{"issue":"10","key":"183_CR41","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.humpath.2013.05.003","volume":"44","author":"N Kumari","year":"2013","unstructured":"Kumari N, Prabha K, Singh RK, Baitha DK, Krishnani N. Intestinal and pancreatobiliary differentiation in periampullary carcinoma: the role of immunohistochemistry. Hum Pathol. 2013;44(10):2213\u20139.","journal-title":"Hum Pathol"},{"issue":"3","key":"183_CR42","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/MPA.0000000000000280","volume":"44","author":"MJ Kwon","year":"2015","unstructured":"Kwon MJ, Jeon JY, Park HR, Nam ES, Cho SJ, Shin HS, et al. Low frequency of KRAS mutation in pancreatic ductal adenocarcinomas in Korean patients and its prognostic value. Pancreas. 2015;44(3):484\u201392.","journal-title":"Pancreas"},{"issue":"7457","key":"183_CR43","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499(7457):214\u20138.","journal-title":"Nature"},{"issue":"2","key":"183_CR44","doi-asserted-by":"publisher","first-page":"R66","DOI":"10.1186\/bcr3172","volume":"14","author":"DS Lee","year":"2012","unstructured":"Lee DS, Yoon SY, Looi LM, Kang P, Kang IN, Sivanandan K, et al. Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1\/2 screening to early-onset breast cancer patients. Breast Cancer Res. 2012;14(2):R66.","journal-title":"Breast Cancer Res"},{"key":"183_CR45","doi-asserted-by":"crossref","unstructured":"Lepre MG, Omar SI, Grasso G, Morbiducci U, Deriu MA, Tuszynski JA. Insights into the effect of the G245S single point mutation on the structure of p53 and the binding of the protein to DNA. Molecules. 2017;22(8).","DOI":"10.3390\/molecules22081358"},{"issue":"11","key":"183_CR46","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1097\/JTO.0b013e3182272273","volume":"6","author":"L Liu","year":"2011","unstructured":"Liu L, Wu C, Wang Y, Zhong R, Duan S, Wei S, et al. Combined effect of genetic polymorphisms in P53, P73, and MDM2 on non-small cell lung cancer survival. J Thorac Oncol. 2011;6(11):1793\u2013800.","journal-title":"J Thorac Oncol"},{"issue":"11","key":"183_CR47","doi-asserted-by":"publisher","first-page":"3988","DOI":"10.1073\/pnas.0500215102","volume":"102","author":"B Ma","year":"2005","unstructured":"Ma B, Pan Y, Gunasekaran K, Venkataraghavan RB, Levine AJ, Nussinov R. Comparison of the protein-protein interfaces in the p53-DNA crystal structures: towards elucidation of the biological interface. Proc Natl Acad Sci U S A. 2005;102(11):3988\u201393.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"183_CR48","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev.pathmechdis.3.121806.154305","volume":"3","author":"A Maitra","year":"2008","unstructured":"Maitra A, Hruban RH. Pancreatic cancer. Annu Rev Pathol. 2008;3:157\u201388.","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"183_CR49","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3945\/an.116.012211","volume":"7","author":"S McGuire","year":"2016","unstructured":"McGuire S. World Cancer report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO press, 2015. Adv Nutr. 2016;7(2):418\u20139.","journal-title":"Adv Nutr"},{"issue":"5","key":"183_CR50","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/modpathol.2013.185","volume":"27","author":"K Mikhitarian","year":"2014","unstructured":"Mikhitarian K, Pollen M, Zhao Z, Shyr Y, Merchant NB, Parikh A, et al. Epidermal growth factor receptor signaling pathway is frequently altered in ampullary carcinoma at protein and genetic levels. Mod Pathol. 2014;27(5):665\u201374.","journal-title":"Mod Pathol"},{"issue":"3","key":"183_CR51","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/0022-2836(90)90371-R","volume":"216","author":"J Milner","year":"1990","unstructured":"Milner J, Medcalf EA. Temperature-dependent switching between \"wild-type\" and \"mutant\" forms of p53-Val135. J Mol Biol. 1990;216(3):481\u20134.","journal-title":"J Mol Biol"},{"key":"183_CR52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1476-4598-2-7","volume":"2","author":"PS Moore","year":"2003","unstructured":"Moore PS, Beghelli S, Zamboni G, Scarpa A. Genetic abnormalities in pancreatic cancer. Mol Cancer. 2003;2:7.","journal-title":"Mol Cancer"},{"issue":"3","key":"183_CR53","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ccr.2014.01.021","volume":"25","author":"PA Muller","year":"2014","unstructured":"Muller PA, Vousden KH. Mutant p53 in cancer: new functions and therapeutic opportunities. Cancer Cell. 2014;25(3):304\u201317.","journal-title":"Cancer Cell"},{"issue":"3","key":"183_CR54","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/MPA.0b013e3182327a03","volume":"41","author":"M Oliveira-Cunha","year":"2012","unstructured":"Oliveira-Cunha M, Hadfield KD, Siriwardena AK, Newman W. EGFR and KRAS mutational analysis and their correlation to survival in pancreatic and periampullary cancer. Pancreas. 2012;41(3):428\u201334.","journal-title":"Pancreas"},{"issue":"3","key":"183_CR55","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s12032-013-0617-5","volume":"30","author":"H Patil","year":"2013","unstructured":"Patil H, Korde R, Kapat A. KRAS gene mutations in correlation with clinicopathological features of colorectal carcinomas in Indian patient cohort. Med Oncol. 2013;30(3):617.","journal-title":"Med Oncol"},{"issue":"6","key":"183_CR56","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/humu.20495","volume":"28","author":"A Petitjean","year":"2007","unstructured":"Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat. 2007;28(6):622\u20139.","journal-title":"Hum Mutat"},{"issue":"13","key":"183_CR57","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004;25(13):1605\u201312.","journal-title":"J Comput Chem"},{"issue":"10","key":"183_CR58","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-11-2612","volume":"72","author":"IA Prior","year":"2012","unstructured":"Prior IA, Lewis PD, Mattos C. A comprehensive survey of Ras mutations in cancer. Cancer Res. 2012;72(10):2457\u201367.","journal-title":"Cancer Res"},{"issue":"17","key":"183_CR59","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr407","volume":"39","author":"B Reva","year":"2011","unstructured":"Reva B, Antipin Y, Sander C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res. 2011;39(17):e118.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"183_CR60","doi-asserted-by":"publisher","first-page":"a001016","DOI":"10.1101\/cshperspect.a001016","volume":"2","author":"AI Robles","year":"2010","unstructured":"Robles AI, Harris CC. Clinical outcomes and correlates of TP53 mutations and cancer. Cold Spring Harb Perspect Biol. 2010;2(3):a001016.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"6","key":"183_CR61","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/humu.20980","volume":"30","author":"A Rohlin","year":"2009","unstructured":"Rohlin A, Wernersson J, Engwall Y, Wiklund L, Bjork J, Nordling M. Parallel sequencing used in detection of mosaic mutations: comparison with four diagnostic DNA screening techniques. Hum Mutat. 2009;30(6):1012\u201320.","journal-title":"Hum Mutat"},{"issue":"4","key":"183_CR62","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1053\/j.gastro.2010.12.039","volume":"140","author":"M Rowley","year":"2011","unstructured":"Rowley M, Ohashi A, Mondal G, Mills L, Yang L, Zhang L, et al. Inactivation of Brca2 promotes Trp53-associated but inhibits KrasG12D-dependent pancreatic cancer development in mice. Gastroenterology. 2011;140(4):1303\u201313 e1\u20133.","journal-title":"Gastroenterology"},{"issue":"17","key":"183_CR63","doi-asserted-by":"publisher","first-page":"5092","DOI":"10.1158\/0008-5472.CAN-16-0658","volume":"76","author":"V Sandhu","year":"2016","unstructured":"Sandhu V, Wedge DC, Bowitz Lothe IM, Labori KJ, Dentro SC, Buanes T, et al. The genomic landscape of pancreatic and Periampullary adenocarcinoma. Cancer Res. 2016;76(17):5092\u2013102.","journal-title":"Cancer Res"},{"issue":"14","key":"183_CR64","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/bioinformatics\/bts271","volume":"28","author":"CT Saunders","year":"2012","unstructured":"Saunders CT, Wong WS, Swamy S, Becq J, Murray LJ, Cheetham RK. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics. 2012;28(14):1811\u20137.","journal-title":"Bioinformatics"},{"issue":"1","key":"183_CR65","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/ijc.10446","volume":"100","author":"U Sen","year":"2002","unstructured":"Sen U, Sankaranarayanan R, Mandal S, Ramanakumar AV, Parkin DM, Siddiqi M. Cancer patterns in eastern India: the first report of the Kolkata cancer registry. Int J Cancer. 2002;100(1):86\u201391.","journal-title":"Int J Cancer"},{"issue":"Web Server issu","key":"183_CR66","doi-asserted-by":"publisher","first-page":"W452","DOI":"10.1093\/nar\/gks539","volume":"40","author":"NL Sim","year":"2012","unstructured":"Sim NL, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 2012;40(Web Server issue):W452\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"183_CR67","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3109\/07357907.2014.1001894","volume":"33","author":"N Singh","year":"2015","unstructured":"Singh N, Gupta S, Pandey RM, Chauhan SS, Saraya A. High levels of cell-free circulating nucleic acids in pancreatic cancer are associated with vascular encasement, metastasis and poor survival. Cancer Investig. 2015;33(3):78\u201385.","journal-title":"Cancer Investig"},{"issue":"11","key":"183_CR68","first-page":"1223","volume":"9","author":"RJ Slebos","year":"2000","unstructured":"Slebos RJ, Hoppin JA, Tolbert PE, Holly EA, Brock JW, Zhang RH, et al. K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study. Cancer Epidemiol Biomark Prev. 2000;9(11):1223\u201332.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"3","key":"183_CR69","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/1096-9098(200011)75:3<176::AID-JSO5>3.0.CO;2-W","volume":"75","author":"MM Song","year":"2000","unstructured":"Song MM, Nio Y, Dong M, Tamura K, Furuse K, Tian YL, et al. Comparison of K-ras point mutations at codon 12 and p21 expression in pancreatic cancer between Japanese and Chinese patients. J Surg Oncol. 2000;75(3):176\u201385.","journal-title":"J Surg Oncol"},{"issue":"5","key":"183_CR70","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s12262-015-1365-x","volume":"77","author":"P Thapa","year":"2015","unstructured":"Thapa P. Epidemiology of pancreatic and Periampullary Cancer. Indian J Surg. 2015;77(5):358\u201361.","journal-title":"Indian J Surg"},{"issue":"2","key":"183_CR71","first-page":"213","volume":"15","author":"G Uomo","year":"2014","unstructured":"Uomo G. Periampullary carcinoma: some important news in histopathology. JOP. 2014;15(2):213\u20135.","journal-title":"JOP"},{"issue":"Web Server issu","key":"183_CR72","doi-asserted-by":"publisher","first-page":"W235","DOI":"10.1093\/nar\/gkp287","volume":"37","author":"M van Dijk","year":"2009","unstructured":"van Dijk M, Bonvin AM. 3D-DART: a DNA structure modelling server. Nucleic Acids Res. 2009;37(Web Server issue):W235\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"183_CR73","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jmb.2015.09.014","volume":"428","author":"GCP van Zundert","year":"2016","unstructured":"van Zundert GCP, Rodrigues J, Trellet M, Schmitz C, Kastritis PL, Karaca E, et al. The HADDOCK2.2 web server: user-friendly integrative modeling of biomolecular complexes. J Mol Biol. 2016;428(4):720\u20135.","journal-title":"J Mol Biol"},{"issue":"4","key":"183_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174865","volume":"12","author":"VK Vincent-Chong","year":"2017","unstructured":"Vincent-Chong VK, Salahshourifar I, Woo KM, Anwar A, Razali R, Gudimella R, et al. Genome wide profiling in oral squamous cell carcinoma identifies a four genetic marker signature of prognostic significance. PLoS One. 2017;12(4):e0174865.","journal-title":"PLoS One"},{"issue":"7540","key":"183_CR75","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature14169","volume":"518","author":"N Waddell","year":"2015","unstructured":"Waddell N, Pajic M, Patch AM, Chang DK, Kassahn KS, Bailey P, et al. Whole genomes redefine the mutational landscape of pancreatic cancer. Nature. 2015;518(7540):495\u2013501.","journal-title":"Nature"},{"issue":"16","key":"183_CR76","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164.","journal-title":"Nucleic Acids Res"},{"key":"183_CR77","doi-asserted-by":"crossref","unstructured":"Waters AM, Der CJ. KRAS: the critical driver and therapeutic target for pancreatic Cancer. Cold Spring Harb Perspect Med. 2018;8(9).","DOI":"10.1101\/cshperspect.a031435"},{"key":"183_CR78","doi-asserted-by":"publisher","first-page":"6744","DOI":"10.1038\/ncomms7744","volume":"6","author":"AK Witkiewicz","year":"2015","unstructured":"Witkiewicz AK, McMillan EA, Balaji U, Baek G, Lin WC, Mansour J, et al. Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets. Nat Commun. 2015;6:6744.","journal-title":"Nat Commun"},{"issue":"2","key":"183_CR79","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ccell.2015.12.012","volume":"29","author":"S Yachida","year":"2016","unstructured":"Yachida S, Wood LD, Suzuki M, Takai E, Totoki Y, Kato M, et al. Genomic sequencing identifies ELF3 as a driver of Ampullary carcinoma. Cancer Cell. 2016;29(2):229\u201340.","journal-title":"Cancer Cell"},{"issue":"4","key":"183_CR80","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1101\/gad.275776.115","volume":"30","author":"H Ying","year":"2016","unstructured":"Ying H, Dey P, Yao W, Kimmelman AC, Draetta GF, Maitra A, et al. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 2016;30(4):355\u201385.","journal-title":"Genes Dev"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-020-00183-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-020-00183-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-020-00183-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T23:39:50Z","timestamp":1623886790000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-020-00183-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,17]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["183"],"URL":"https:\/\/doi.org\/10.1186\/s10020-020-00183-1","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,17]]},"assertion":[{"value":"26 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors sincerely thank the participants for their help and willingness to take part in this study. Patient samples were collected from two State Government Hospitals (Medical College & Hospital, Kolkata, SSKM & I.P.G.M.E.&R Hospital, Kolkata), Government of West Bengal, and two private hospitals Calcutta Medical Research Institute (CMRI), a C. K. Birla Hospital and Tata Medical Center (TMC), Rajarhat, Kolkata. The study was approved by the Institutional Review Board (IRB) of Indian Statistical Institute, Kolkata and also from all above mentioned Hospitals. The consents were taken from each patient and their families for this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No consent was involved in this publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}